Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes After Predischarge Initiation of β-Blocker in Patients Hospitalized for Severe Decompensated Heart Failure Requiring Inotropic Therapy.
Cho MS, Kim MS, Lee SE, Choi HI, Lee JB, Cho HJ, Lee HY, Choi JO, Jeon ES, Hwang KK, Chae SC, Baek SH, Kang SM, Choi DJ, Yoo BS, Ahn Y, Kim KH, Park HY, Cho MC, Oh BH, Kim JJ. Cho MS, et al. Among authors: ahn y. Can J Cardiol. 2018 Sep;34(9):1145-1152. doi: 10.1016/j.cjca.2018.05.005. Epub 2018 May 9. Can J Cardiol. 2018. PMID: 30170669
Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC. Hong SN, et al. Among authors: ahn y. Am J Cardiol. 2007 Apr 15;99(8):1051-4. doi: 10.1016/j.amjcard.2006.11.069. Epub 2007 Mar 6. Am J Cardiol. 2007. PMID: 17437726
Positive remodeling is associated with more plaque vulnerability and higher frequency of plaque prolapse accompanied with post-procedural cardiac enzyme elevation compared with intermediate/negative remodeling in patients with acute myocardial infarction.
Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, Kang WY, Lee SE, Kim SH, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Hong YJ, et al. Among authors: ahn y. J Cardiol. 2009 Apr;53(2):278-87. doi: 10.1016/j.jjcc.2008.12.006. Epub 2009 Feb 13. J Cardiol. 2009. PMID: 19304134 Free article.
Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction.
Sim DS, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Sim DS, et al. Among authors: ahn y. Am J Cardiol. 2009 May 15;103(10):1333-8. doi: 10.1016/j.amjcard.2009.01.339. Epub 2009 Mar 25. Am J Cardiol. 2009. PMID: 19427424
A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
Kim HK, Jeong MH, Ahn Y, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi DH, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, Rha SW, Bae JH, Cho JG, Park SJ; other Korea Acute Myocardial Infarction Registry Investigators; Korea Acute Myocardial infarction Registry (KAMIR) Study Group of Korean Circulation Society. Kim HK, et al. Among authors: ahn y. Int J Cardiol. 2010 Dec 3;145(3):450-4. doi: 10.1016/j.ijcard.2009.06.001. Epub 2009 Jun 21. Int J Cardiol. 2010. PMID: 19541376
Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry).
Lee JH, Park HS, Chae SC, Cho Y, Yang DH, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH; Korea Acute Myocardial Infarction Registry Investigators. Lee JH, et al. Am J Cardiol. 2009 Jul 15;104(2):182-9. doi: 10.1016/j.amjcard.2009.03.010. Am J Cardiol. 2009. PMID: 19576343
Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, Kang WY, Lee SE, Kim SH, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Hong YJ, et al. Among authors: ahn y. J Cardiol. 2009 Aug;54(1):36-44. doi: 10.1016/j.jjcc.2009.03.003. Epub 2009 Apr 19. J Cardiol. 2009. PMID: 19632518 Free article.
A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mg.
Lee CW, Baek SH, Hong TJ, Choi YJ, Kim YJ, Ahn TH, Ihm SH, Bae JH, Hong SJ, Kim DI, Ahn YK, Hur SH, Park DG, Choi DJ, Lee SU, Kim BS, Ryu KH, Jang YS, Lee SH, Seung KB, Kim HS. Lee CW, et al. Cardiovasc Drugs Ther. 2010 Apr;24(2):181-8. doi: 10.1007/s10557-010-6225-0. Cardiovasc Drugs Ther. 2010. PMID: 20383571 Clinical Trial.
4,338 results